Literature DB >> 26430671

Adult granulosa cell tumor presenting with massive ascites, elevated CA-125 level, and low (18)F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.

Ji Young Tak1, Gun Oh Chong1, Ji Y Park2, Seung Jeong Lee1, Yoon Hee Lee1, Dae Gy Hong1.   

Abstract

Adult granulosa cell tumors (AGCTs) presenting with massive ascites and elevated serum CA-125 levels have rarely been described in the literature. An ovarian mass, massive ascites, and elevated serum CA-125 levels in postmenopausal women generally suggest a malignant ovarian tumor, particularly advanced epithelial ovarian cancer. AGCT has low (18)F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography due to its low metabolic activity. In the present report, we describe a case of an AGCT with massive ascites, elevated serum CA-125 level, and low (18)F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography.

Entities:  

Keywords:  18F-fluorodeoxyglucose; Adult granulosa cell tumor; CA-125; Massive ascites; Positron emission tomography/computed tomography

Year:  2015        PMID： 26430671      PMCID： PMC4588851          DOI： 10.5468/ogs.2015.58.5.423

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN： 2287-8572


  14 in total

1.  Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax.

Authors:  J V MEIGS
Journal:  Obstet Gynecol       Date:  1954-05       Impact factor: 7.661

2.  Adult granulosa cell tumor presenting as metastases to the pleural and peritoneal cavity.

Authors:  Nalini Gupta; Arvind Rajwanshi; Pranab Dey; Vanita Suri
Journal:  Diagn Cytopathol       Date:  2011-05-26       Impact factor: 1.582

3.  Ovarian granulosa cell tumor presenting as Meigs' syndrome with elevated CA125.

Authors:  Kwon Choi; Hyun Jong Lee; Ji Cheul Pae; Suk Joong Oh; Seong Yong Lim; Eun Yoon Cho; Seung Sei Lee
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

4.  Clinicopathologic review of 118 granulosa and 82 theca cell tumors.

Authors:  A T Evans; T A Gaffey; G D Malkasian; J F Annegers
Journal:  Obstet Gynecol       Date:  1980-02       Impact factor: 7.661

5.  Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.

Authors:  Tatsuo Torizuka; Shuji Nobezawa; Toshihiko Kanno; Masami Futatsubashi; Etsuji Yoshikawa; Hiroyuki Okada; Munetaka Takekuma; Makoto Maeda; Yasuomi Ouchi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-19       Impact factor: 9.236

6.  Cytomorphology of adult granulosa cell tumor in ascitic fluid.

Authors:  Kalpana Azad; Jitender M Khunger
Journal:  Indian J Pathol Microbiol       Date:  2010 Jan-Mar       Impact factor: 0.740

Review 7.  Meigs' syndrome with elevated serum CA 125 levels: two case reports and review of the literature.

Authors:  D Timmerman; P Moerman; I Vergote
Journal:  Gynecol Oncol       Date:  1995-12       Impact factor: 5.482

8.  Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography.

Authors:  Yorito Yamamoto; Hiroyoshi Oguri; Ruriko Yamada; Nagamasa Maeda; Shino Kohsaki; Takao Fukaya
Journal:  Int J Gynaecol Obstet       Date:  2008-04-18       Impact factor: 3.561

9.  Juvenile granulosa cell tumor of the ovary presenting with pleural effusion and ascites.

Authors:  Harpreet Kaur; Rashmi Bagga; Subhash Chandra Saha; Shalini Gainder; Radhika Srinivasan; Amit K Adhya; Lakhbir Kaur Dhaliwal
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

10.  Massive ascites as the only sign of ovarian juvenile granulosa cell tumor in an adolescent: a case report and a review of the literature.

Authors:  Azin Ashnagar; Samin Alavi; Yalda Nilipour; Roxana Azma; Farahnaz Falahati
Journal:  Case Rep Oncol Med       Date:  2013-01-29
View more
  1 in total

Review 1.  Adult-type granulosa cell tumor of the ovary.

Authors:  Xiuwen Li; Bo Tian; Mengyan Liu; Chunlei Miao; Di Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.